The tet-off system is more effective than the tet-on system for regulating transgene expression in a single adenovirus vector

Journal of Gene Medicine

Volumn 4, Issue 3, 2002, Pages 240-247

  Mizuguchi, Hiroyuki ^a   Hayakawa, Takao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Adenovirus vector; Gene regulation; Gene therapy; Tetracycline

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; DOXYCYCLINE; LUCIFERASE; TETRACYCLINE; REPRESSOR PROTEIN; TETRACYCLINE RESISTANCE ENCODING TRANSPOSON REPRESSOR PROTEIN; TETRACYCLINE RESISTANCE-ENCODING TRANSPOSON REPRESSOR PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; GENE FUNCTION; GENE THERAPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; VIRAL GENE DELIVERY SYSTEM; ADENOVIRUS; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; PHYSIOLOGY; PLASMID; TRANSGENE;

ADENOVIRIDAE; MAMMALIA;

ADENOVIRIDAE; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HUMANS; PLASMIDS; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 0036581969     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.261     Document Type: Article

References (31)

1. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992; 89: 5547-5551.
2. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
3. Benihoud K, Yeh P, Perricaudet M. Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999; 10: 440-447.
4. Kovesdi I, Brough D, Bruder J, Wickham T. Adenoviral vectors for gene transfer. Curr Opin Biotechnol 1997; 8: 583-589.
5. Mizuguchi H, Kay MA, Hayakawa T. In vitro ligation-based cloning of foreign DNAs into the E3 as well as E1 deletion region for generation of recombinant adenovirus vector. BioTechniques 2001; 30: 1112-1116.
6. Heffelfinger SC, Hawkins HH, Barrish J, Taylor L, Darlington GJ. SK HEP-1: a human cell line of endothelial origin. In Vitro Cell Dev Biol 1992; 28A: 136-142.
7. Asaoka K, Tada M, Sawamura Y, Ikeda J, Abe H. Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor. J Neurosurg 2000; 92: 1002-1008.
8. Takahashi K, Sawasaki Y, Hata J, Mukai K, Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 1990; 26: 265-274.
9. Mizuguchi H, Kay MA. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum Gene Ther 1998; 9: 2577-2583.
10. Mizuguchi H, Kay MA. A simple method for constructing E1 and E1/E4 deleted recombinant adenovirus vector. Hum Gene Ther 1999; 10: 2013-2017.
11. Chapman BS, Thayer RM, Vincent KA, Haigwood NL. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res 1991; 19: 3979-3986.
12. Mizuguchi H, Koizumi N, Hosono T, et al. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther. 2001; 8: 730-735.
13. Kanegae Y, Makimura M, Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 1994; 47: 157-166.
14. Hu SX, Ji W, Zhou Y, Logothetis C, Xu HJ. Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression. Cancer Res 1997; 57: 3339-3343.
15. Corti O, Sabate O, Horellou P, et al. A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors. Nature Biotechnol 1999; 17: 349-354.
16. Ghersa P, Gobert RP, Sattonnet-Roche P, Richards CA, Merlo Pich E, Hooft van Huijsduijnen R. Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor. Gene Ther 1998; 5 1213-1220.
17. Harding TC, Geddes BJ, Noel JD, Murphy D, Uney JB. Tetracycline-regulated transgene expression in hippocampal neurones following transfection with adenoviral vectors. J Neurochem 1997; 69: 2620-2603.
18. Harding TC, Geddes BJ, Murphy D, Knight D, Uney JB. Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system. Nature Biotechnol 1998; 16: 553-555.
19. Molin M, Shoshan MC, Ohman-Forslund K, Linder S, Akusjarvi G. Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments. J Virol 1998; 72: 8358-8361.
20. Baron U, Schnappinger D, Helbl V, Gossen M, Hillen W, Bujard H. Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc Natl Acad Sci U S A 1999; 96: 1013-1018.
21. Xu Z-L, Mizuguchi H, Ishii-Watabe A, Uchida E, Mayumi T, Hayakawa T. Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene 2001; 272: 149-156.
22. A-Mohammadi S, Hawkins RE. Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system. Gene Ther 1998; 5: 76-84.
23. Yin DX, Zhu L, Schimke RT. Tetracycline-controlled gene expression system achieves high-level and quantitative control of gene expression. Anal Biochem 1996; 235: 195-201.
24. Wood M, Perrotte P, Onishi E, et al. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther 1999; 6: 367-372.
25. Huard J, Lochmuller H, Acsadi G, Jani A, Massie B, Karpati G. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 1995; 2: 107-115.
26. Chastain M, Simon A, Soper K, et al. Antigen levels and antibody titers after DNA vaccination. J Pharm Sci 2001; 90: 474-484.
27. A-Mohammadi S, Alvarez-Vallina L, Ashworth LJ, Hawkins RE. Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analogues. Gene Ther 1997; 4 993-997.
28. Serguera C, Bohl D, Rolland E, Prevost P, Heard JM. Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cells. Hum Gene Ther 1999; 10: 375-383.
29. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard. H, Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 2000; 97: 7963-7968.
30. Caplen NJ, Higginbotham JN, Scheel JR, et al. Adeno-retroviral chimeric viruses as in vivo transducing agents. Gene Ther 1999; 6: 454-459.
31. Tremblay P, Meiner Z, Galou M, et al. Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proc Natl Acad Sci U S A 1998; 95: 12580-12585.